Research News
View articles by month and year
-
One Year of Herceptin Best for Reducing Recurrence Risk of Early-Stage HER2-Positive Disease
Results from two studies confirm that 1 year of Herceptin, rather than 2 years or 6 months, after surgery seems to be best for reducing recurrence risk in women diagnosed with HER2-positive early-stage breast cancer.
-
Needle Biopsy May Lead to Better Treatment Outcomes Than Open Biopsy
A study has found that diagnosing breast cancer with a needle biopsy instead of a traditional open surgical biopsy is more efficient, less invasive, and may lead to better treatment outcomes.
-
T-DM1 Lengthens Survival in Women Diagnosed with HER2-Positive Advanced-Stage Disease
Women diagnosed with HER2-positive advanced-stage breast cancer lived longer when they got the experimental medicine T-DM1 compared to women who got a different targeted therapy regimen.
-
Regular Screening Helps Reduce Difference in Breast Cancer Outcomes Between African American and White Women
A study suggests that regular screening mammograms can help improve the outcomes of African American women diagnosed with breast cancer.
-
MRI Before Surgery Doesn’t Reduce Need for More Surgery Later On
A study suggests that having an MRI before initial breast cancer surgery doesn’t reduce the likelihood that a woman would need more breast cancer surgery later.
-
New Screening Device for Dense Breasts Approved by FDA
The FDA has approved an automated ultrasound device to screen for breast cancer in women with dense breasts.
-
Study Analyzes Breast Cancer Genetics, Finds Four Classes of Disease
Researchers have done the most thorough analysis of breast cancer genetics to date and found that there are four genetically distinct classes of the disease.
-
Mammograms Save Lives, Benefits Outweigh Concerns
A European study has found that for every 1,000 women between the ages of 50 and 70 who get a mammogram every 2 years, seven to nine lives are saved.
-
Use of Anthracyclines to Treat Breast Cancer Has Gone Down
A study has found that after 2005, there was a large increase in taxane chemotherapy and a decrease in anthracycline chemotherapy to treat breast cancer in the United States.
-
Genetic Counseling Before Surgery Can Lower Stress and Help Women Make Decisions
A small study has found that women diagnosed with breast cancer who are offered genetic counseling before breast cancer surgery have less stress and make more informed decisions about treatment compared to women who don’t get genetic counseling before surgery.
